tm logo

Monitor this mark

View On USPTO

RUXIENCE
Live/Registered
REGISTERED

on 13 Oct 2020

Last Applicant/ Owned by

Pfizer Inc.

66 Hudson Boulevard East

New York

NY

100012192

Serial Number

88023071 filed on 02th Jul 2018

Registration Number

6175690 registered on 13th Oct 2020

in the Principal Register

Correspondent Address

Richard A. Friedman

Richard A. Friedman

66 Hudson Boulevard East

NEW YORK NY 10001-2192

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

RUXIENCE

Pharmaceutical preparations for the treatment of autoimmune, and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of cancer

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of autoimmune, and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of cancer

First Use Date in General

31st Jan 2020

First Use Date in Commerce

31st Jan 2020

Mark Details

Serial Number

No 88023071

Mark Type

No Service/Collective Mark

Attorney Docket Number

No T423495

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
28th Mar 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
28th Mar 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
28th Mar 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28th Mar 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
28th Mar 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
13th Oct 2020REGISTERED-PRINCIPAL REGISTER
09th Sep 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08th Sep 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
26th Aug 2020STATEMENT OF USE PROCESSING COMPLETE
26th Aug 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL